Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
Epirubicin
TOP2
TOP
7861.017
uM
0.25036
0.80531
-0.9757 -0.8847 0.8718 0.7806
0.9887
1.8068
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7472.092
uM
inf
inf
1.0174 1.0174 0.0000 -0.0459
-20.4790
1.2676
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7474.09
uM
inf
inf
1.0500 1.0500 0.0000 -0.0177
-0.3118
2.4405
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7471.092
uM
inf
inf
-0.3277 -0.3277 0.0000 0.7586
-0.0557
0.3860
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
10379.092
uM
90.50410
757.49670
0.6506 -1.0000 0.5171 0.0829
0.7673
2.5811
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7473.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.3297
Hs 578T
TNBC
Basal B
Erlotinib
EGFR
ErbB
7475.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
2.6839
Hs 578T
TNBC
Basal B
Etoposide
TOP2
TOP
7475.074
uM
6.17310
10.49360
-0.7940 -0.6193 1.5188 0.3945
0.9715
2.4793
Hs 578T
TNBC
Basal B
Etoposide
TOP2
TOP
7472.074
uM
11.96570
14.17630
-0.6937 -0.6671 5.0000 0.3973
0.9945
1.5922
Hs 578T
TNBC
Basal B
Etoposide
TOP2
TOP
7474.074
uM
6.21020
8.89680
-0.6288 -0.5755 2.1305 0.4129
0.9955
2.6218
Hs 578T
TNBC
Basal B
Etoposide
TOP2
TOP
7473.074
uM
7.38250
9.0670
-0.4978 -0.4637 3.1924 0.3952
0.9970
2.5364
Hs 578T
TNBC
Basal B
Fascaplysin
CDK4
CDK
7473.084
uM
0.95755
1.15660
-0.9410 -0.7856 4.9994 0.4445
0.9889
2.0337
Hs 578T
TNBC
Basal B
Fascaplysin
CDK4
CDK
7474.084
uM
0.83282
1.00080
-0.8699 -0.7532 5.0000 0.4995
0.9908
2.6631
Hs 578T
TNBC
Basal B
Fascaplysin
CDK4
CDK
7475.084
uM
0.86639
1.04980
-0.8415 -0.8056 4.9999 0.4773
0.9973
2.7804
Hs 578T
TNBC
Basal B
FR180204
ERK1/2
MAPK
10694.149
uM
inf
inf
0.9542 0.9542 0.0000 0.0010
0.4579
2.3563
Hs 578T
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10694.154
uM
inf
inf
0.9764 0.9764 0.0000 -0.0084
-0.0364
2.3045
Hs 578T
TNBC
Basal B
Gefitinib
EGFR
ErbB
7864.016
uM
34.76760
37.50720
0.5230 -0.0824 2.0104 0.0610
0.8868
1.4893
Hs 578T
TNBC
Basal B
Gefitinib
EGFR
ErbB
7861.016
uM
9.68140
16.81060
-0.5950 -1.0000 1.9909 0.2241
0.9544
2.0473
Hs 578T
TNBC
Basal B
Gefitinib
EGFR
ErbB
7862.016
uM
26.62450
28.66980
0.3047 -0.1303 3.1298 0.0522
0.9551
1.3229
Hs 578T
TNBC
Basal B
Gefitinib
EGFR
ErbB
7863.016
uM
24.11230
39.92670
0.2219 -0.9065 2.0508 0.0723
0.9834
1.7699
Hs 578T
TNBC
Basal B
Geldanamycin
HSP90
HSP90
9511.012
uM
0.02880
0.05161
-0.5604 -0.4151 1.0360 0.8079
0.9749
1.2568
Hs 578T
TNBC
Basal B
Geldanamycin
HSP90
HSP90
7862.04
uM
0.08575
0.11793
-0.5151 -0.4589 2.0433 0.7824
0.9896
1.4556
Hs 578T
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7864.011
uM
1.67230
1.46940
0.1733 0.2381 5.0000 0.2906
0.9134
1.4831
Hs 578T
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7862.011
uM
0.06272
0.05076
0.0913 0.1315 1.4424 0.5464
0.9506
1.3695
Hs 578T
TNBC
Basal B
Gemcitabine
DNA replication
DNA replication
7863.011
uM
5.23790
4.73310
0.0692 0.0626 1.3206 0.2615
0.9938
2.0237